Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.30 SEK
−49.73 M SEK
50.90 M SEK
139.65 M
About ENZYMATICA AB
Sector
Industry
CEO
Claus Egstrand
Website
Headquarters
Lund
Founded
2007
ISIN
SE0003943620
FIGI
BBG001Y25Z66
Enzymatica AB engages in the research, development, and sale of medical technology products. It offers medical devices in upper respiratory infections and oral health. The company was founded by Ulf Blom, Jorgen Rexo, Ake Larsson, and Staffan Bergqvist in 2007 and is headquartered in Lund, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ENZY is 1.63 SEK — it has decreased by −2.40% in the past 24 hours. Watch ENZYMATICA AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ENZYMATICA AB stocks are traded under the ticker ENZY.
ENZY stock hasn't changed in a week, the month change is a −6.32% fall, over the last year ENZYMATICA AB has showed a −49.78% decrease.
ENZY reached its all-time high on Feb 12, 2013 with the price of 31.42 SEK, and its all-time low was 1.53 SEK and was reached on Aug 5, 2024. View more price dynamics on ENZY chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ENZY stock is 11.33% volatile and has beta coefficient of 0.39. Track ENZYMATICA AB stock price on the chart and check out the list of the most volatile stocks — is ENZYMATICA AB there?
Today ENZYMATICA AB has the market capitalization of 395.66 M, it has decreased by −3.47% over the last week.
Yes, you can track ENZYMATICA AB financials in yearly and quarterly reports right on TradingView.
ENZYMATICA AB is going to release the next earnings report on Feb 18, 2025. Keep track of upcoming events with our Earnings Calendar.
ENZYMATICA AB revenue for the last quarter amounts to 12.60 M SEK, despite the estimated figure of 21.80 M SEK. In the next quarter, revenue is expected to reach 35.60 M SEK.
ENZY net income for the last quarter is −7.25 M SEK, while the quarter before that showed −13.79 M SEK of net income which accounts for 47.47% change. Track more ENZYMATICA AB financial stats to get the full picture.
No, ENZY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 18.00 employees. See our rating of the largest employees — is ENZYMATICA AB on this list?
Like other stocks, ENZY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENZYMATICA AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ENZYMATICA AB technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ENZYMATICA AB stock shows the sell signal. See more of ENZYMATICA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.